[
  {
    "ts": null,
    "headline": "BDX Stock Declines Following Class I Classification for Alaris Recall",
    "summary": "BD's recall of Alaris infusion pumps following software issues has been classified as the most severe recall by the FDA. A suspension of sales may hurt the top line going forward.",
    "url": "https://finnhub.io/api/news?id=83fccc5361b72d2805b1320ca38558c2624ed0728498d6bd34fdf260c53ca637",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742985180,
      "headline": "BDX Stock Declines Following Class I Classification for Alaris Recall",
      "id": 133448407,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "BD's recall of Alaris infusion pumps following software issues has been classified as the most severe recall by the FDA. A suspension of sales may hurt the top line going forward.",
      "url": "https://finnhub.io/api/news?id=83fccc5361b72d2805b1320ca38558c2624ed0728498d6bd34fdf260c53ca637"
    }
  }
]